Atossa Therapeutics Inc (NASDAQ: ATOS) started the day on Wednesday, with a price decrease of -5.30% at $0.6, before settling in for the price of $0.64 at the close. Taking a more long-term approach, ATOS posted a 52-week range of $0.55-$1.29.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 36.92%. Meanwhile, its Annual Earning per share during the time was 36.92%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -25.00%. This publicly-traded company’s shares outstanding now amounts to $129.17 million, simultaneously with a float of $129.10 million. The organization now has a market capitalization sitting at $77.76 million.
Atossa Therapeutics Inc (ATOS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Atossa Therapeutics Inc’s current insider ownership accounts for 0.06%, in contrast to 19.41% institutional ownership. According to the most recent insider trade that took place on May 21 ’25, this organization’s President & CEO bought 11,239 shares at the rate of 0.88, making the entire transaction reach 9,887 in total value, affecting insider ownership by 13,898. Preceding that transaction, on Mar 26 ’25, Company’s Director bought 10,000 for 0.70, making the whole transaction’s value amount to 7,000. This particular insider is now the holder of 10,257 in total.
Atossa Therapeutics Inc (ATOS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
Atossa Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -25.00% and is forecasted to reach -0.29 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -17.57% through the next 5 years, which can be compared against the 36.92% growth it accomplished over the previous five years trading on the market.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Let’s observe the current performance indicators for Atossa Therapeutics Inc (ATOS). It’s Quick Ratio in the last reported quarter now stands at 6.77.
In the same vein, ATOS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.23, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be -0.29 at the market close of one year from today.
